An influenza vaccine candidate from Moderna showed promising results in a late-stage trial, bringing the drug maker one step ...

Moderna's new flu vaccine, based on the same mRNA technology used in its COVID-19 shot, showed promising results in a major ...

Moderna Inc. said Monday its experimental flu shot showed positive results in a late-stage trial.   In a Phase 3 study, the ...

The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50, down from 60, following ...

Moderna this week announced positive data from a phase 3 trial of its messenger RNA vaccine against seasonal influenza, which ...

A new CDC vaccine panel, handpicked by RFK Jr., released an updated list of recommended vaccines. However, only if the ...

The virus has not yet evolved to spread efficiently between people. Excellent vaccine technology exists, but the government ...

The loss of a vote on COVID-19 vaccines is perhaps not surprising, since Kennedy already unilaterally altered CDC recommendations for those vaccines, restricting their use in healthy children and ...

Moderna in May voluntarily withdrew an application seeking approval of its combination shot targeting Covid-19 and influenza ... Americans were hospitalized due to flu-related illness last year, ...

A newly posted agenda for next week’s meeting of the just-appointed group of outside vaccine advisers to the US Centers for Disease Control and Prevention includes a discussion and vote on thimerosal ...

U.S. Health Secretary Robert F. Kennedy Jr.’s new vaccine advisers meet next week. Their agenda suggests they’ll skip some expected topics, including a vote on COVID-19 shots.

Measles outbreaks. A canceled effort to develop a bird flu vaccine. An infectious new COVID variant and changing federal guidance about who should get boosted. In recent weeks, drama in D.C. has ...